NCT06994845: Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
- State
- Under way
- Phase
- Phase 3
- People
- 31 planned
- Started
- 27 Nov 2025
- Primary completion
- 28 Jun 2030
- Arms
- iptacopan
- Results
- None posted
- 29 May 2025: Trial registered
- 27 Nov 2025: Trial started